Orthopedics maker Small Bone raises $15M

Led by Viscogliosi Brothers with the the help of Malaysian investment firm Khazanah Nasional Berhad, Small Bone Innovations has raised $15 million of Series F preferred shares. The orthopedics company, which has offices in the U.S., Europe and Asia, is developing technology for joint repair and trauma reconstruction around the small bone joints of the thumb, fingers, hand, wrist, elbow, toe, foot and ankle, according to the company's announcement. Its lead product is the STAR total ankle join replacement system.

CEO Anthony Viscogliosi plans to use the money to invest in expanding the STAR brand, as well as the company's stable core upper limb arthroplasty and trauma reconstruction portfolio of products. "We are highly encouraged with STAR's performance, as well as the tremendous patient and surgeon feedback it has been receiving. We are committed to investing more in STAR's future to better serve appropriate patients who would benefit from this technology in order to restore the form, function and motion of their ankle."

- here's SBi's release

ALSO: Minnesota-based Cardiovascular Systems has raised $5 million from the sale of debt, according to documents filed with the Securities and Exchange Commission. The company is developing a device, called Diamondback 360, that removes plaque from peripheral vessels in the pelvis or leg, according to MinnPost. Report

Suggested Articles

Cellex has announced plans to develop a rapid coronavirus test that people can fully perform at home, from sample collection to result, using an app.

More than 20 states either don’t release or have incomplete data on the rapid antigen tests now considered key to containing the coronavirus.

Since launching Grail into the world in 2016, Illumina has watched the cancer blood test developer grow into a multibillion-dollar startup enterprise.